Page not found

Search results

  1. Vanderbilt-Ancora partnership advances research for rare form of epilepsy 

    ... by mutations in a gene that affects neurotransmission in the brain and can result in abnormal electrical activity, such as seizures. These ... compound. The work, in conjunction with the  Center for Technology Transfer and Commercialization , will continue to be led by  C. ...

    sommers - 10/31/2022 - 12:18pm

  2. Two Vanderbilt faculty win ‘TIME’ Best Inventions of 2022

    ... early   James Weimer , assistant professor of computer science and faculty affiliate of the Vanderbilt Institute for Surgery ... focuses on the Internet of Medical Things and developing technology that collects the right data to provide actionable feedback to ...

    sommers - 12/05/2022 - 12:15pm

  3. Small Molecule-GIRK Potassium Channel Modulators That Are Anxiolytic Therapeutics

    ... (VU0456810) and demonstrated that ML297 is active in animal models of epilepsy. While the group is using ML297 to continue to explore the therapeutic benefits of GIRK modulation, ...

    cttc_admin - 01/23/2024 - 1:38pm

  4. Continuum Robots with Equilibrium Modulation (CREM)

    ... in surgical contexts. The present continuum robot technology’s novel method of equilibrium modulation can be used for both ... invasive surgery (MIS) and industrial applications. Technology Description The technology revolves around continuum robots ... Figure 1. Image (a) A parallel robot using CREM (b) A continuum snake-like robot using CREM Commercial ...

    cttc_admin - 02/14/2024 - 8:48am

  5. Vanderbilt-Ancora partnership advances research for Charcot-Marie-Tooth disease

    ... of biochemistry and associate director of the  Vanderbilt Brain Institute .   “Professors Sanders and Carter are true ... partnership with Deerfield and grateful to the Center for Technology Transfer and Commercialization team—particularly Alan Bentley and ...

    sommers - 11/17/2020 - 2:53pm

  6. Small Molecule mGlu3 NAMs as Therapeutics for CNS Disorders

    ... These dual specific compounds have shown efficacy in models for:   Anxiety or OCD (Eur J. Pharmacol, 2008, 592, ... 2010, 30, 3870) Addiction Withdrawal (Behav. Brain Res. 2013, 246, 24)   In efforts to determine which ...

    cttc_admin - 01/23/2024 - 4:43pm

  7. Vanderbilt inks collaboration with Neumora Therapeutics, Inc to continue development of investigational treatment for neuropsychiatric disorders

    ... biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience.   ... Thomas Utley, senior licensing officer at the  Center for Technology Transfer and Commercialization . “The team that Neumora has put ...

    sommers - 05/06/2022 - 10:50am

  8. Low-Frequency Strain Energy Harvester

    ... impossible to efficiently leverage human motion for energy using current technology. The proposed device overcomes this with ultrathin materials that ...

    cttc_admin - 02/02/2024 - 4:41pm

  9. MAESTRO: Non-Robotic Dexterous Laparoscopic Instrument with a Wrist providing seven degrees of freedom

    ... is an intuitive user interface for the surgeon. Technology Description The surgical manipulator offers surgeons a ... enhanced by the absence of a return spring. A motion compensation mechanism to compensate for the natural mirror image effects ...

    cttc_admin - 08/17/2023 - 5:28pm

  10. Predictive models for gene regulation

    ... analysis yield far more precise, reproducible and predictive models of the complex mechanisms that control gene expression profiles over ...

    sommers - 08/21/2018 - 8:34am